Search Results 871-880 of 17831 for Hepatitis b

1. A Study of Vascular Dysfunction in Polycystic Kidney Disease (PKD) - Mayo Clinic

   Concomitant systemic disease in the kidney (e.g., lupus, hepatitis B or C, amyloidosis, glomerular disease). Diabetes mellitus trea tment with insulin or ...

2. PR3-AAV Resilient Remission or PRRR - Clinical Trials

   - Infection (blood borne): active hepatitis B or active hepatitis C or a documented history of HIV, hepatitis B, or hepatitis C. - Infection (history): ...

3. Nivolumab in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Cancer - Mayo Clinic

   ... hepatitis B and/or Child-Pugh Class B or C cirrhosis; however, patients with adequately controlled hepatitis are not excluded from the study if they satisfy ...

4. Study of REGN2810 (Anti-PD-1) in Patients With Advanced Malignancies - Mayo Clinic

   ... hepatitis B or hepatitis C virus, except for designated cohorts that allow hepatitis or HIV (Patients with hepatitis B on antiviral therapy or patients with ...

5. Efficacy and Safety of Vedolizumab Subcutaneous (SC) as Maintenance Therapy in Crohn's Disease - Mayo Clinic

   HBV immune participants (ie, being hepatitis B surface antigen [HBsAg] negative and hepatitis B antibody positive) may, however, be included. History of any ...

6. A Study of Idasanutlin in Combination With Obinutuzumab in Relapsed/Refractory (R/R) Follicular Lymphoma (FL) and in Combination With Rituximab in R/R Diffuse Large B-Cell Lymphoma (DLBCL) Participants - Mayo Clinic

   ... B-Cell Lymphoma (DLBCL) Participants. Print details. Share; Facebook ... Positive for human immunodeficiency virus (HIV) or hepatitis B or C; Receipt ...

7. A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy - Mayo Clinic

   Known Human Immunodeficiency Virus (HIV), active Hepatitis B Virus (HBV), and/or active Hepatitis C Virus (HCV) infection. Prior therapy with lenalidomide ...

8. Study of Pembrolizumab (MK-3475) in Combination With Dinaciclib (MK-7965) in Hematologic Malignancies (MK-3475-155) - Mayo Clinic

   Has a known history of or is positive for hepatitis B (hepatitis B surface antigen reactive) or hepatitis C (hepatitis C virus RNA [qualitative] is detected) ...

9. A Study of Investigational Immunotherapy to Determine the Safety and Effectiveness of Nivolumab and Daratumumab, with or without Pomalidomide and Dexamethasone, in Patients with Relapsed/Refractory Hematologic Malignancies - Mayo Clinic

   Seropositive for hepatitis B (defined by a positive test for hepatitis B surface antigen [HBsAg]). Subjects with resolved infection (i.e., subjects who are ...

10. Study Comparing Daratumumab, Lenalidomide, and Dexamethasone With Lenalidomide and Dexamethasone in Participants With Previously Untreated Multiple Myeloma - Mayo Clinic

    ... B (defined by a positive test for hepatitis B surface antigen [HBsAg] or antibodies to hepatitis B surface and core antigens [anti-HBs and anti-HBc ...